Mr. Stan Lis reports

LEANLIFE HEALTH INC. ANNOUNCES AGM RESULTS AND OFFICER CHANGES

LeanLife Health Inc.'s shareholders voted in favour of all resolutions brought forth at the company's annual general meeting of shareholders held in Vancouver, B.C., on Jan. 4, 2019.

Resolutions that were proposed and approved (99.96 per cent) at the meeting included the following:

1. Setting the number of directors of the company at five;
2. Election of the following directors of the company for the ensuing year:
   1. Stan Lis;
   2. Glen Macdonald;
   3. Marcin Lukaszewicz;
   4. Robert Chanson;
   5. Casey Forward;
3. Appointment of Charlton and Company, chartered professional accountant, as auditor of the corporation for the ensuing year;
4. Ratifying the company's stock option plan as described in the information circular.

For health reasons, Mr. Forward had to resign as a director and later as chief financial officer on Jan. 9, 2019.

Jason Tong, CPA, CA, CFA, of Vancouver, has been appointed CFO following the resignation of Mr. Forward. Mr. Tong has served in senior management positions for a number of public and private companies in his career. Mr. Tong was previously the chief financial officer of Pathway Capital Ltd., a venture capital firm with a portfolio of early-stage ventures with market capitalization ranging from $5-million to $100-million. Mr. Tong was the chief financial officer of Turnberry Resources Ltd. from February, 2012, until the company was acquired in April, 2014. Currently, Mr. Tong is the chief financial officer of ExGen Resources Inc. and is a senior adviser to several high-growth companies.

About LeanLife Health Inc.

LeanLife Health's products are extracted from flax seeds, a plentiful and non-animal source of omega-3. The products can be used as a food additive or as a nutraceutical and have been used to make bread, noodles, cheese, yogurt, juice and milk products for the European market.

LeanLife Health's industry-leading omega-3 product formulations are of the highest quality and contain no cholesterol.

The global omega-3 market is expected to reach $7.32-billion (U.S.) by 2020, according to a report by Grand View Research Inc.